Skip to Primary Navigation

Skip to main content

Health trio sues leading healthcare company for ‘siphoning’  340B funds

A photo of a square red sign with "Rx" printed in gray at center.
Photo: Smith Collection/Gado/Getty Images

Kevin Kinsella

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The plaintiffs allege that the company and its affiliates diverted funds that should have been passed through to hospitals participating in the drug-pricing program.

Three major US health systems have filed federal lawsuits accusing CVS Health and several of its affiliates of improperly withholding roughly $250m in savings tied to the 340B drug pricing program.

According to a press release from healthcare law firm Frier Levitt, the plaintiffs – Mount Sinai Health System

The health

, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience